Table 1. Demographic and clinical characteristics of the 211 study participants.

CharacteristicsN (%)*	All patients(n = 211)	HIV-seropositive(n = 170)	HIV-seronegative(n = 41)
Median age, years (IQR)	35 (28–42)	34 (28–39)	48 (34–62)
Women	114 (54)	97 (57)	17 (41)
Taking antibiotics prior to admission	139 (66)	115 (68)	24 (59)
Median CD4+ T-cell count, cells/µL (IQR)	- -	139 (29–203)	- -
Taking co-trimoxazole prophylaxis on admission	- -	94 (55)	- -
Taking antiretroviral therapy on admission	- -	29 (17)	- -
Culture-confirmed TB	75 (36)	67 (39)	8 (20)
Clinically confirmed or culture-confirmed TB	92 (55)†	81 (61)††	11 (32)†††
Two-month mortality	46 (24)§	41 (26)§§	5 (14)§§§

Abbreviations: IQR, inter-quartile range; N, number; TB, tuberculosis.

Legend:

*Characteristics presented as number and column percentage unless otherwise indicated. Missing or indeterminate results reduced the number at risk in the superscripted subsets as follows:

^†N = 167;

^††N = 133;

^†††N = 34;

^§N = 193;

^§§N = 157;

^§§§N = 36.